Hypertension in Pregnancy

Papers
(The TQCC of Hypertension in Pregnancy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
A clinical and in-silico study exploring the association of CASP-3, NF-kB, miR-187, and miR-146 in pre-eclampsia16
Risk of gestational hypertension and preeclampsia in pregnant women with new onset blood pressure of 120–129/≤89 mmHg: a meta-analysis of prospective studies11
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial11
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China10
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients10
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates10
Inflammasomes in placental explants of women with preeclampsia cultured with monosodium urate may be modulated by vitamin D10
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials10
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk9
Intraabdominal pressure as a marker for physiologic and pathologic processes in pregnancy9
Pre-eclampsia screening with maternal risk factors and ophthalmic Doppler artery: a systematic review9
Targeting oxidative stress in preeclampsia7
Statement of Retraction: Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section7
Predictability of adverse outcomes in hypertensive disorders of pregnancy: a multicenter prospective cohort study6
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies5
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio5
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy5
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy5
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis5
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter4
Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?4
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study4
Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis4
Examining the relationship between maternal preeclampsia and autism spectrum disorder in childhood4
Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia3
Relationship between the hemodynamic profile and resistant hypertension in pregnant patients with hypertensive crisis3
Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort3
The obesity associated FTO gene polymorphism and the risk of preeclampsia in Iranian women: A case–control study3
Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks3
MiR-140-5p exerts a protective function in pregnancy-induced hypertension via mediating TGF-β/Smad signaling pathway3
0.06823205947876